Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma

Damlaj, M., Abuelgasim, K. A., Alhejazi, A., Alahmari, B., Alaskar, A., & Alzahrani, M. (2020, December 1). Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma. Bone Marrow Transplantation. Springer Nature. https://doi.org/10.1038/s41409-020-0935-0